+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5189611
  • Report
  • October 2020
  • Region: Global
  • 271 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Aarhus University
  • Columbia University
  • Hycor Biomedical Inc
  • Metanomics Health GmbH
  • ProciseDx LLC
  • Svar Life Science AB
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

This report provides comprehensive information about the Auto-Immune Diseases Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Auto-Immune Diseases Diagnostic Tests Pipeline Assessment report provides key information and data related to:


  • Extensive coverage of the Auto-Immune Diseases Diagnostic Tests under development
  • Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates
  • Reviews of major players involved in the pipeline product development
  • Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Auto-Immune Diseases Diagnostic Tests pipeline products
  • Review of Recent Developments in the segment / industry

The Alzheier Diagnostic Tests Pipeline Assessment report enables you to:


  • Access significant competitor information, analysis, and insights to improve your R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Drainage Device sunder development
  • Formulate market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type


Data and analysis in this report includes the following:


  • 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
  • 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
  • 64,000+ medical equipment company profiles
  • 5,600+ company profiles of medical equipment manufacturers in China and India
  • 2,200+ company profiles of medical equipment manufacturers in Japan
  • 1,200+ companies’ revenue splits and market shares
  • 1,600+ quarterly and annual medical equipment company financials
  • 850+ medical equipment company SWOTs
  • 28,000+ pipeline product profiles
  • 56,400+ marketed product profiles
  • 47,000+ clinical trials
  • 41,500+ trial investigators
  • 7,000+ reports on companies with products in development
  • 44,000+ deals in the medical equipment industry
  • 1,100+ surgical and diagnostic procedures by therapy area
  • 50+ key healthcare indicators by country
  • 431,000+ Themes Content Items
  • 600+ Influencers
  • 1,900+ Analysts & Researchers
  • 0.5m+ Community Members
  • 141,000+ Macroeconomic Indicators
  • 1,013,000+ City Indicators

Report Scope


  • Extensive coverage of the Auto-Immune Diseases Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Auto-Immune Diseases Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

The report enables you to:


  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Auto-Immune Diseases Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aarhus University
  • Columbia University
  • Hycor Biomedical Inc
  • Metanomics Health GmbH
  • ProciseDx LLC
  • Svar Life Science AB

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Auto-Immune Diseases Overview
3 Products under Development
3.1 Auto-Immune Diseases - Pipeline Products by Stage of Development
3.2 Auto-Immune Diseases - Pipeline Products by Territory
3.3 Auto-Immune Diseases - Pipeline Products by Regulatory Path
3.4 Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
3.5 Auto-Immune Diseases - Ongoing Clinical Trials
4 Auto-Immune Diseases - Pipeline Products under Development by Companies
4.1 Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
4.2 Auto-Immune Diseases - Pipeline Products by Stage of Development
5 Auto-Immune Diseases Companies and Product Overview
5.1 Aarhus University Company Overview
5.1.1 Aarhus University Pipeline Products & Ongoing Clinical Trials Overview
5.2 Adaptive Biotechnologies Corp Company Overview
5.2.1 Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Albert Ludwigs University of Freiburg Company Overview
5.3.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
5.4 Alere Inc Company Overview
5.4.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Amarantus Diagnostics Inc Company Overview
5.5.1 Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 apDia nv Company Overview
5.6.1 apDia nv Pipeline Products & Ongoing Clinical Trials Overview
5.7 Autoimmune Technologies LLC Company Overview
5.7.1 Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Beckman Coulter Inc Company Overview
5.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Bellvitge Biomedical Research Institute Company Overview
5.9.1 Bellvitge Biomedical Research Institute Pipeline Products & Ongoing Clinical Trials Overview
5.10 BG Medicine Inc Company Overview
5.10.1 BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Biogen Inc Company Overview
5.11.1 Biogen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 BIOHOPE Scientific SL Company Overview
5.12.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
5.13 Biomedal SL Company Overview
5.13.1 Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview
5.14 Bionure Farma SL Company Overview
5.14.1 Bionure Farma SL Pipeline Products & Ongoing Clinical Trials Overview
5.15 CDI Laboratories Inc Company Overview
5.15.1 CDI Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Celdara Medical LLC Company Overview
5.16.1 Celdara Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Charite University Hospital of Berlin Company Overview
5.17.1 Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview
5.18 Chronix Biomedical Inc Company Overview
5.18.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Cincinnati Children’s Hospital Medical Center Company Overview
5.19.1 Cincinnati Children’s Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.20 Columbia University Company Overview
5.20.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
5.21 Crescendo Bioscience Inc Company Overview
5.21.1 Crescendo Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Digna Biotech SL Company Overview
5.22.1 Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
5.23 DNAlytics SA Company Overview
5.23.1 DNAlytics SA Pipeline Products & Ongoing Clinical Trials Overview
5.24 Enterome Bioscience SA Company Overview
5.24.1 Enterome Bioscience SA Pipeline Products & Ongoing Clinical Trials Overview
5.25 Exodus Biosciences LLC Company Overview
5.25.1 Exodus Biosciences LLC Pipeline Products & Ongoing Clinical Trials Overview
5.26 Ezose Sciences Inc. Company Overview
5.26.1 Ezose Sciences Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.27 Flamentera AG Company Overview
5.27.1 Flamentera AG Pipeline Products & Ongoing Clinical Trials Overview
5.28 Genalyte Inc Company Overview
5.28.1 Genalyte Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 GeNeuro SA Company Overview
5.29.1 GeNeuro SA Pipeline Products & Ongoing Clinical Trials Overview
5.30 Grifols SA Company Overview
5.30.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
5.31 Hannover Medical School Company Overview
5.31.1 Hannover Medical School Pipeline Products & Ongoing Clinical Trials Overview
5.32 HealthTell Inc Company Overview
5.32.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview
5.33 Helmholtz Centre for Infection Research Company Overview
5.33.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview
5.34 HOB Biotech Group Suzhou Co Ltd Company Overview
5.34.1 HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 Hospital for Special Surgery Company Overview
5.35.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
5.36 Hycor Biomedical Inc Company Overview
5.36.1 Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 Ignyta Inc Company Overview
5.37.1 Ignyta Inc Pipeline Products & Ongoing Clinical Trials Overview
5.38 Immunarray Pvt Ltd Company Overview
5.38.1 Immunarray Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.39 Immunodiagnostic Systems Holdings plc Company Overview
5.39.1 Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview
5.40 Immunovia AB Company Overview
5.40.1 Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview
5.41 ImmusanT Inc Company Overview
5.41.1 ImmusanT Inc Pipeline Products & Ongoing Clinical Trials Overview
5.42 Innobiochips Company Overview
5.42.1 Innobiochips Pipeline Products & Ongoing Clinical Trials Overview
5.43 Inova Diagnostics Inc Company Overview
5.43.1 Inova Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.44 IPDx Immunoprofiling Diagnostics GmbH Company Overview
5.44.1 IPDx Immunoprofiling Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.45 Iquity Labs Inc Company Overview
5.45.1 Iquity Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
5.46 Iron Horse Diagnostics, Inc. Company Overview
5.46.1 Iron Horse Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.47 Johns Hopkins University Company Overview
5.47.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
5.48 Lankenau Institute for Medical Research Company Overview
5.48.1 Lankenau Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.49 LineaGen Inc Company Overview
5.49.1 LineaGen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.50 Lophius Biosciences GmbH Company Overview
5.50.1 Lophius Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.51 Louisville Bioscience Inc (Inactive) Company Overview
5.51.1 Louisville Bioscience Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.52 Max Delbruck Center for Molecular Medicine Company Overview
5.52.1 Max Delbruck Center for Molecular Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.53 Medica Corp Company Overview
5.53.1 Medica Corp Pipeline Products & Ongoing Clinical Trials Overview
5.54 Medical & Biological Laboratories Co Ltd Company Overview
5.54.1 Medical & Biological Laboratories Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.55 Metabiomics Corporation Company Overview
5.55.1 Metabiomics Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.56 Metabolomic Technologies Inc Company Overview
5.56.1 Metabolomic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.57 Metanomics Health GmbH Company Overview
5.57.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.58 MSDx Inc Company Overview
5.58.1 MSDx Inc Pipeline Products & Ongoing Clinical Trials Overview
5.59 Myriad Genetics Inc Company Overview
5.59.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.60 Nanosphere Inc Company Overview
5.60.1 Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.61 Neuro Vigor LLC Company Overview
5.61.1 Neuro Vigor LLC Pipeline Products & Ongoing Clinical Trials Overview
5.62 Northwestern University Company Overview
5.62.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.63 NoToPharm srl Company Overview
5.63.1 NoToPharm srl Pipeline Products & Ongoing Clinical Trials Overview
5.64 Numares AG Company Overview
5.64.1 Numares AG Pipeline Products & Ongoing Clinical Trials Overview
5.65 OmniBiome Therapeutics Inc Company Overview
5.65.1 OmniBiome Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.66 One Way Liver SL Company Overview
5.66.1 One Way Liver SL Pipeline Products & Ongoing Clinical Trials Overview
5.67 OPKO Health Inc Company Overview
5.67.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.68 Op-T-Mune Inc Company Overview
5.68.1 Op-T-Mune Inc Pipeline Products & Ongoing Clinical Trials Overview
5.69 Oxford Gene Technology Ltd Company Overview
5.69.1 Oxford Gene Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.70 Oxford Immunotec Ltd Company Overview
5.70.1 Oxford Immunotec Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.71 Pediatric Bioscience LLC Company Overview
5.71.1 Pediatric Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview
5.72 Penn State College of Medicine Company Overview
5.72.1 Penn State College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.73 ProciseDx LLC Company Overview
5.73.1 ProciseDx LLC Pipeline Products & Ongoing Clinical Trials Overview
5.74 Progentec Diagnostics Inc Company Overview
5.74.1 Progentec Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.75 Protagen AG Company Overview
5.75.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview
5.76 ProteinLogic Ltd Company Overview
5.76.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.77 Quanterix Corp Company Overview
5.77.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview
5.78 Rambam Health Care Campus Company Overview
5.78.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview
5.79 Rappaport Family Institute for Research in the Medical Science Company Overview
5.79.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview
5.80 Regulus Therapeutics Inc Company Overview
5.80.1 Regulus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.81 Roche Diagnostics International Ltd Company Overview
5.81.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.82 Seattle Children’s Hospital Company Overview
5.82.1 Seattle Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.83 Sengenics Corp Pte Ltd Company Overview
5.83.1 Sengenics Corp Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.84 Sequenom Inc Company Overview
5.84.1 Sequenom Inc Pipeline Products & Ongoing Clinical Trials Overview
5.85 Shuwen Biotech Co Ltd Company Overview
5.85.1 Shuwen Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.86 SomaLogic Inc Company Overview
5.86.1 SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.87 Southern Illinois University Carbondale Company Overview
5.87.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
5.88 SQI Diagnostics Inc Company Overview
5.88.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.89 Statens Serum Institut Company Overview
5.89.1 Statens Serum Institut Pipeline Products & Ongoing Clinical Trials Overview
5.90 Svar Life Science AB Company Overview
5.90.1 Svar Life Science AB Pipeline Products & Ongoing Clinical Trials Overview
5.91 TBG Diagnostics Ltd Company Overview
5.91.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.92 The University of Manchester Company Overview
5.92.1 The University of Manchester Pipeline Products & Ongoing Clinical Trials Overview
5.93 The Walter and Eliza Hall Institute of Medical Research Company Overview
5.93.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.94 Toscana Biomarkers Srl Company Overview
5.94.1 Toscana Biomarkers Srl Pipeline Products & Ongoing Clinical Trials Overview
5.95 University Health Network Company Overview
5.95.1 University Health Network Pipeline Products & Ongoing Clinical Trials Overview
5.96 University of Alberta Company Overview
5.96.1 University of Alberta Pipeline Products & Ongoing Clinical Trials Overview
5.97 University of California San Francisco Company Overview
5.97.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.98 University of Chicago Company Overview
5.98.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.99 University of Colorado Company Overview
5.99.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.100 University of Illinois at Chicago Company Overview
5.100.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
5.101 University of Maryland Baltimore Company Overview
5.101.1 University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview
5.102 University of Missouri Company Overview
5.102.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
5.103 University of Oslo Company Overview
5.103.1 University of Oslo Pipeline Products & Ongoing Clinical Trials Overview
5.104 University of Oxford Company Overview
5.104.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.105 University of Pecs Company Overview
5.105.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview
5.106 University of Southern California Company Overview
5.106.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
5.107 University Rovira i Virgili Company Overview
5.107.1 University Rovira i Virgili Pipeline Products & Ongoing Clinical Trials Overview
5.108 US Biomarkers Inc Company Overview
5.108.1 US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview
5.109 Washington University in St Louis Company Overview
5.109.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
5.110 XEPTAGEN SpA Company Overview
5.110.1 XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
5.111 Yale University Company Overview
5.111.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview
6 Auto-Immune Diseases - Recent Developments
6.1 Aug 04, 2020: Oxford Immunotec reports second quarter 2020 financial results
6.2 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia
6.3 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.4 Jun 04, 2020: Alpine Immune Sciences presents preclinical data on novel dual BAFF/APRIL inhibitory domains for B cell mediated autoimmune diseases at the European Congress of Rheumatology E-Congress 2020
6.5 Jun 02, 2020: EGFR biology, inhibitors & ADCC
6.6 May 28, 2020: QIAGEN builds on leading position in Precision Medicine with novel solutions in oncology
6.7 May 18, 2020: QIAGEN announces publication of Reasoned Position Statement for proposed acquisition by Thermo Fisher and date for Annual General Meeting
6.8 May 13, 2020: OPKO Health’s BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services
6.9 May 12, 2020: CHDR announces addition of premises with supplementary office space in the Leiden Bio Science Park!
6.10 Mar 09, 2020: Exagen partners with three California medical groups to offer AVISE testing as covered in-network benefit for their patients
6.11 Mar 02, 2020: Neon Therapeutics reports fourth quarter and full year 2019 financial results and provides business update
6.12 Feb 27, 2020: Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million
6.13 Feb 27, 2020: CareDx reports fourth quarter and full year 2019 results
6.14 Feb 27, 2020: SQI Diagnostics reports first quarter 2020 results
6.15 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors
6.16 Feb 26, 2020: Adaptive Biotechnologies reports fourth quarter and full year 2019 financial results
6.17 Feb 14, 2020: Immunovia full year report 2019
6.18 Feb 13, 2020: Bio-Rad reports fourth-quarter and full-year 2019 financial results
6.19 Feb 10, 2020: Luminex reports fourth quarter and full-year 2019 results
6.20 Feb 06, 2020: Myriad announces leadership transition
6.21 Feb 06, 2020: Myriad Genetics reports fiscal second-quarter 2020 financial results
6.22 Feb 04, 2020: Bio-Rad brings FCS express flow cytometry analysis software to ZE5 cell analyzer users
6.23 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
6.24 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results
6.25 Jan 30, 2020: The Crown Princess of Sweden and Prince Daniel visited Immunovia in Lund
6.26 Jan 30, 2020: Theradiag reports 2019 revenue of €9.6 million, Up 8.3%
6.27 Jan 30, 2020: OGT launches breakthrough NGS panel for constitutional cytogenetics
6.28 Jan 21, 2020: Adaptive announces preliminary unaudited revenue for full year 2019
6.29 Jan 14, 2020: Dr. Thomas P. Slavin named Senior Vice President of Medical Affairs for Myriad Oncology
6.30 Jan 13, 2020: Immunovia strengthen management with new senior VP of Sales North America ahead of the IMMray PanCan-d Test launch
6.31 Jan 13, 2020: CareDx reports preliminary fourth quarter and full year 2019 results
6.32 Jan 08, 2020: CareDx’s false advertising complaint upheld by court
6.33 Jan 06, 2020: Bio-Rad appoints Dara Grantham Wright Executive Vice President and Clinical Diagnostics Group President
6.34 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control
6.35 Dec 24, 2019: Ad-hoc announcement pursuant to article 17 market abuse regulation
6.36 Dec 23, 2019: The International Trade Commission issues final decision affirming 10X Genomics infringement of three of Bio-Rad’s Patents
6.37 Dec 13, 2019: Bio-Rad makes progress recovering from recent ransomware attack
6.38 Dec 11, 2019: SQI Diagnostics Reports Fourth Quarter and Fiscal 2019 Results and Management Changes
6.39 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
6.40 Nov 22, 2019: Exagen extends agreement with GSK for a third year to drive greater awareness about challenges facing lupus diagnosis and management
6.41 Nov 15, 2019: QIAGEN receives several conditional, non-binding indications of interest, enters into discussions to explore potential strategic alternatives
6.42 Nov 13, 2019: Thermo Fisher Scientific opens Customer Solution Center in China to support pharmaceutical and biopharmaceutical laboratories
6.43 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance
6.44 Nov 12, 2019: Neon Therapeutics reports third quarter 2019 financial results and recent highlights
6.45 Nov 12, 2019: Regulus Therapeutics reports third quarter 2019 financial results and recent updates
6.46 Nov 12, 2019: Adaptive Biotechnologies reports third quarter 2019 financial results
6.47 Nov 12, 2019: OGT continues move into molecular diagnostics markets
6.48 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI
6.49 Nov 05, 2019: Oxford Immunotec reports third quarter 2019 financial results
6.50 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results
7 Appendix
7.1 Methodology
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Aarhus University
  • Adaptive Biotechnologies Corp
  • Albert Ludwigs University of Freiburg
  • Alere Inc
  • Amarantus Diagnostics Inc
  • apDia nv
  • Autoimmune Technologies LLC
  • Beckman Coulter Inc
  • Bellvitge Biomedical Research Institute
  • BG Medicine Inc
  • Biogen Inc
  • BIOHOPE Scientific SL
  • Biomedal SL
  • Bionure Farma SL
  • CDI Laboratories Inc
  • Celdara Medical LLC
  • Charite University Hospital of Berlin
  • Chronix Biomedical Inc
  • Cincinnati Children’s Hospital Medical Center
  • Columbia University
  • Crescendo Bioscience Inc
  • Digna Biotech SL
  • DNAlytics SA
  • Enterome Bioscience SA
  • Exodus Biosciences LLC
  • Ezose Sciences Inc.
  • Flamentera AG
  • Genalyte Inc
  • GeNeuro SA
  • Grifols SA
  • Hannover Medical School
  • HealthTell Inc
  • Helmholtz Centre for Infection Research
  • HOB Biotech Group Suzhou Co Ltd
  • Hospital for Special Surgery
  • Hycor Biomedical Inc
  • Ignyta Inc
  • Immunarray Pvt Ltd
  • Immunodiagnostic Systems Holdings plc
  • Immunovia AB
  • ImmusanT Inc
  • Innobiochips
  • Inova Diagnostics Inc
  • IPDx Immunoprofiling Diagnostics GmbH
  • Iquity Labs Inc
  • Iron Horse Diagnostics, Inc.
  • Johns Hopkins University
  • Lankenau Institute for Medical Research
  • LineaGen Inc
  • Lophius Biosciences GmbH
  • Louisville Bioscience Inc (Inactive)
  • Max Delbruck Center for Molecular Medicine
  • Medica Corp
  • Medical & Biological Laboratories Co Ltd
  • Metabiomics Corporation
  • Metabolomic Technologies Inc
  • Metanomics Health GmbH
  • MSDx Inc
  • Myriad Genetics Inc
  • Nanosphere Inc
  • Neuro Vigor LLC
  • Northwestern University
  • NoToPharm srl
  • Numares AG
  • OmniBiome Therapeutics Inc
  • One Way Liver SL
  • Op-T-Mune Inc
  • OPKO Health Inc
  • Oxford Gene Technology Ltd
  • Oxford Immunotec Ltd
  • Pediatric Bioscience LLC
  • Penn State College of Medicine
  • ProciseDx LLC
  • Progentec Diagnostics Inc
  • Protagen AG
  • ProteinLogic Ltd
  • Quanterix Corp
  • Rambam Health Care Campus
  • Rappaport Family Institute for Research in the Medical Science
  • Regulus Therapeutics Inc
  • Roche Diagnostics International Ltd
  • Seattle Children’s Hospital
  • Sengenics Corp Pte Ltd
  • Sequenom Inc
  • Shuwen Biotech Co Ltd
  • SomaLogic Inc
  • Southern Illinois University Carbondale
  • SQI Diagnostics Inc
  • Statens Serum Institut
  • Svar Life Science AB
  • TBG Diagnostics Ltd
  • The University of Manchester
  • The Walter and Eliza Hall Institute of Medical Research
  • Toscana Biomarkers Srl
  • University Health Network
  • University of Alberta
  • University of California San Francisco
  • University of Chicago
  • University of Colorado
  • University of Illinois at Chicago
  • University of Maryland Baltimore
  • University of Missouri
  • University of Oslo
  • University of Oxford
  • University of Pecs
  • University of Southern California
  • University Rovira i Virgili
  • US Biomarkers Inc
  • Washington University in St Louis
  • XEPTAGEN SpA
  • Yale University
Note: Product cover images may vary from those shown